These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1469538)

  • 1. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.
    Angiolella L; Bromuro C; Simonetti N; Cassone A
    J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
    Angiolella L; Simonetti N; Cassone A
    J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aculeacin A on reverting protoplasts of Candida albicans.
    Yamaguchi H; Hiratani T; Baba M; Osumi M
    Microbiol Immunol; 1987; 31(7):625-38. PubMed ID: 3325782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans.
    Angiolella L; Facchin M; Simonetti N; Cassone A
    J Chemother; 1995 Apr; 7(2):83-9. PubMed ID: 7666125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
    Hall GS; Myles C; Pratt KJ; Washington JA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
    Rennie RP; Hellman L
    Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
    Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction.
    Ko YT; Ludescher RD; Frost DJ; Wasserman BP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1378-85. PubMed ID: 8092841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic.
    Angiolella L; Maras B; Stringaro AR; Arancia G; Mondello F; Girolamo A; Palamara AT; Cassone A
    J Chemother; 2005 Aug; 17(4):409-16. PubMed ID: 16167521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of yeast isolates to amphotericin B and other antifungal inhibitors of beta-glucan synthesis].
    García M; Nogués A; Herrero E
    Enferm Infecc Microbiol Clin; 1995 Mar; 13(3):151-6. PubMed ID: 7734494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the antifungal activity of LY121019, a new echinocandin derivative.
    Strippoli V; D'Auria FD; Simonetti N
    Chemioterapia; 1988 Feb; 7(1):33-7. PubMed ID: 3288366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy.
    Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC
    J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics.
    Angiolella L; Facchin M; Stringaro A; Maras B; Simonetti N; Cassone A
    J Infect Dis; 1996 Mar; 173(3):684-90. PubMed ID: 8627033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin.
    Richardson MD; Smyth LA; Shankland GS
    FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and structure-activity relationships of simplified analogues of the antifungal agent cilofungin: a total synthesis approach.
    Zambias RA; Hammond ML; Heck JV; Bartizal K; Trainor C; Abruzzo G; Schmatz DM; Nollstadt KM
    J Med Chem; 1992 Jul; 35(15):2843-55. PubMed ID: 1495015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Candida species to cilofungin (LY-121019).
    Torres-Rodriguez JM; Carrillo-Muñoz A; Gallach-Bau C; Madrenys N
    Mycoses; 1989 Jun; 32(6):316-8. PubMed ID: 2779613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase.
    Beaulieu D; Tang J; Yan SB; Vessels JM; Radding JA; Parr TR
    Antimicrob Agents Chemother; 1994 May; 38(5):937-44. PubMed ID: 8067773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.
    Pfaller M; Riley J; Koerner T
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils.
    Meshulam T; Levitz SM; Diamond RD; Sugar AM
    J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.